Proteasome inhibitors in acute leukemia
Proteasome inhibition has been recognized as a novel treatment modality in hematologic
malignancies. Initially, the reversible proteasome inhibitor bortezomib demonstrated efficacy …
malignancies. Initially, the reversible proteasome inhibitor bortezomib demonstrated efficacy …
Proteasome inhibitors in acute leukemia
D Niewerth, I Dingjan, J Cloos… - Expert Review of …, 2013 - search.proquest.com
Proteasome inhibition has been recognized as a novel treatment modality in hematologic
malignancies. Initially, the reversible proteasome inhibitor bortezomib demonstrated efficacy …
malignancies. Initially, the reversible proteasome inhibitor bortezomib demonstrated efficacy …
[引用][C] Proteasome inhibitors in acute leukemia
D Niewerth, I Dingjan, J Cloos, G Jansen… - Expert Review of …, 2013 - cir.nii.ac.jp
Proteasome inhibitors in acute leukemia | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
[引用][C] Proteasome inhibitors in acute leukemia
D Niewerth, I Dingjan, J Cloos… - Expert Review …, 2013 - researchinformation.amsterdamumc …
Proteasome inhibitors in acute leukemia — Amsterdam UMC research portal Skip to main
navigation Skip to search Skip to main content Amsterdam UMC research portal Home …
navigation Skip to search Skip to main content Amsterdam UMC research portal Home …
[引用][C] Proteasome inhibitors in acute leukemia
D NIEWERTH, I DINGJAN, J CLOOS… - Expert review of …, 2013 - pascal-francis.inist.fr
Proteasome inhibitors in acute leukemia CNRS Inist Pascal-Francis CNRS Pascal and
Francis Bibliographic Databases Simple search Advanced search Search by classification …
Francis Bibliographic Databases Simple search Advanced search Search by classification …
[引用][C] Proteasome inhibitors in acute leukemia
D Niewerth - 2014 - research.vu.nl
Proteasome inhibitors in acute leukemia — Vrije Universiteit Amsterdam Skip to main navigation
Skip to search Skip to main content Vrije Universiteit Amsterdam Home Vrije Universiteit …
Skip to search Skip to main content Vrije Universiteit Amsterdam Home Vrije Universiteit …
Proteasome inhibitors in acute leukemia
D Niewerth, I Dingjan, J Cloos… - Expert review of …, 2013 - pubmed.ncbi.nlm.nih.gov
Proteasome inhibition has been recognized as a novel treatment modality in hematologic
malignancies. Initially, the reversible proteasome inhibitor bortezomib demonstrated efficacy …
malignancies. Initially, the reversible proteasome inhibitor bortezomib demonstrated efficacy …
Proteasome inhibitors in acute leukemia
D Niewerth, I Dingjan, J Cloos, G Jansen… - Expert Review of …, 2013 - go.gale.com
Survival of patients suffering from leukemia has improved enormously over the last decades.
Nowadays, for pediatric acute lymphocytic leukemia (ALL) the 5-year overall survival is over …
Nowadays, for pediatric acute lymphocytic leukemia (ALL) the 5-year overall survival is over …
[PDF][PDF] Proteasome inhibitors in acute leukemia
D Niewerth, I Dingjan, J Cloos, G Jansen, G Kaspers - scholar.archive.org
Proteasome inhibition has been recognized as a novel treatment modality in hematologic
malignancies. Initially, the reversible proteasome inhibitor bortezomib (BTZ) demonstrated …
malignancies. Initially, the reversible proteasome inhibitor bortezomib (BTZ) demonstrated …
[PDF][PDF] Proteasome Inhibitors in Acute Leukemia
D Niewerth - 2014 - research.vumc.nl
Acute leukemie omvat ongeveer 30% van alle kanker bij kinderen. In Nederland worden
ongeveer 120 kinderen per jaar met acute lymfatische leukemie (ALL) gediagnostiseerd en …
ongeveer 120 kinderen per jaar met acute lymfatische leukemie (ALL) gediagnostiseerd en …